+91-98 455 710 46 | info@nckpharma.com

Pharma News

Keep updating your pharma knowledge
11 Aug 2020

Insight on First approved COVID-19 vaccine Sputnik V

Russia has announced the launch of first approved covid-19 vaccine. The Covid-19 vaccine brand name is Sputnik V. Sputnik V is developed by Gamaleya Research Institute in collaboration with the Russian Defence Ministry is all set to proceed to the next level of development, as per a statement issued by the country’s deputy Health Minister, Oleg Gridnec. Russia will begin production of the vaccine soon and already has plans for a massive, country-wide vaccine drive.

 

What is the mechanism of action of Sputnik V Covid 19 vaccine

Alexander Gintsburg, director of the Gamaleya National Research Centre, said that vaccine used inanimate particles created on the basis of adenovirus, according to Sputnik News. He said there are no concerns that the vaccine could potentially cause harm to a person’s health.

Some people naturally have a fever when immune system of the person being vaccinated receives a powerful boost but this “side-effect” can easily be overcome by taking paracetamol, he added.

Russia President Vladimir Putin said the vaccine works “quite effectively” and “forms a stable immunity” against Covid-19. 

Duration and Immunization Plan

  • COVID-19 vaccine offers lasting immunity from the virus.
  • The vaccine is expected to provide immunity from the coronavirus for up to two years.

“The two-stage injection plan helps form a lasting immunity. The experience with vector vaccines and two-stage scheme shows that immunity lasts for up to two years”, as per the Russian Health Ministry.

Significance of the covid-19 vaccine brand name Sputnik V

Nearly nine months into the Covid-19 outbreak, Russia became the first country to grant regulatory approval to a Covid-19 vaccine, dubbed “Sputnik V” (a reference to the world’s first satellite), for civilian use, President Vladimir Putin announced on Tuesday, describing it as “a very important step for the world”.Unlike other candidates in the race, Russia has not published any findings from its vaccine trials. It was on July 13 that the reports about Russia claiming their two-part phase I trial was successful came out.

Russia has one more covid-19 vaccine in development

Russia currently has another COVID-19 one more vaccine candidate, that is developed by the Vektor State Research Center of Virology and Biotechnology.

 

 

Leave a Reply

Scale up your Pharma knwledge to Next Level with our Free Content

Case studies & Caselets
Simulation based learning
Online self competency assessment tests 

etc.